Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine in Multimorbid Major Depression and Inflammatory Bowel Disease
NCT06309472Phase 2Completed
- Sponsor
- King's College London
- Start
- May 2024
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
A Phase 2 trial of mirtazapine in major depressive disorder (MDD), sponsored by King's College London. Started May 2024; status: completed.
02
Drugs
mirtazapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06309472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06309472.